Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 15.26% vs NA in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 23.57% vs NA in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -6.92% vs NA in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 36.31% vs NA in Mar 2024
Compare Profit and Loss Results of Onyx Biotec
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
61.00
46.00
15.00
32.61%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
61.00
46.00
15.00
32.61%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
38.00
4.00
34.00
850.00%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
8.00
11.00
-3.00
-27.27%
Operating Expenses
1.00
0.00
1.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
51.00
25.00
26.00
104.00%
Operating Profit (PBDIT) excl Other Income
10.00
20.00
-10.00
-50.00%
Other Income
1.00
4.00
-3.00
-75.00%
Operating Profit (PBDIT)
11.00
25.00
-14.00
-56.00%
Interest
2.00
7.00
-5.00
-71.43%
Profit before Depriciation and Tax
9.00
18.00
-9.00
-50.00%
Depreciation
3.00
9.00
-6.00
-66.67%
Profit Before Taxation & Exceptional Items
6.00
9.00
-3.00
-33.33%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
9.00
-3.00
-33.33%
Provision for Tax
1.00
1.00
0.00
0.00%
Profit After Tax
4.00
7.00
-3.00
-42.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
9.00
21.00
-12.00
-57.14%
Profit Available for appropriations
14.00
29.00
-15.00
-51.72%
Appropriations
14.00
29.00
-15.00
-51.72%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.31
4.95
-1.64
-33.13%
Profit And Loss - Net Sales
Net Sales 61.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 15.26% vs NA in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.37 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.57% vs NA in Mar 2024
Profit And Loss - Interest
Interest 2.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.92% vs NA in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 36.31% vs NA in Mar 2024






